Nabil V. Sayour
Budapest, BU 1089, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Correction: IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning.
Journal: Basic research in cardiology
Published: November 10, 2025
Framingham risk score associates with incident cancer and heart failure.
Journal: European journal of preventive cardiology
Published: June 21, 2025
Framingham risk score associates with incident cancer and heart failure.
Journal: European journal of preventive cardiology
Published: June 21, 2025
Microgliosis, neuronal death, minor behavioral abnormalities and reduced endurance performance in alpha-ketoglutarate dehydrogenase complex deficient mice.
Journal: Redox biology
Published: June 14, 2025
Cyclooxygenase-2 inhibition improves hypercholesterolemia-induced cardiac dysfunction.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 12, 2025
Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register.
Journal: European journal of heart failure
Published: May 07, 2025
Inhibition of the programmed death protein 1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischaemia.
Journal: Cardiovascular research
Published: April 20, 2025
Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide.
Journal: Cardiovascular diabetology
Published: February 28, 2025
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning.
Journal: Basic research in cardiology
Published: October 21, 2024
Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma.
Journal: British journal of pharmacology
Published: July 02, 2024
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors.
Journal: Basic research in cardiology
Published: May 30, 2024
Last Updated: 09/26/2026